Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$32.74
-0.2%
$31.43
$27.07
$40.28
$1.33B1.34250,749 shs416,570 shs
Liquidia Co. stock logo
LQDA
Liquidia
$15.03
+0.2%
$14.71
$8.26
$19.41
$1.28B0.241.08 million shs1.88 million shs
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$5.76
-1.7%
$6.98
$4.54
$10.79
$362.25M0.79591,776 shs238,993 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$19.83
-6.8%
$19.44
$15.75
$53.64
$1.32B1.471.49 million shs1.59 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.00%+0.15%+10.38%+0.99%-0.30%
Liquidia Co. stock logo
LQDA
Liquidia
0.00%-2.08%-5.05%+1.08%+16.78%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.00%-2.04%-20.66%-34.25%-2.04%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
0.00%-4.30%-7.68%-4.57%-61.29%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cadre Holdings, Inc. stock logo
CDRE
Cadre
3.205 of 5 stars
2.51.02.50.03.23.31.9
Liquidia Co. stock logo
LQDA
Liquidia
3.6428 of 5 stars
4.51.00.00.03.24.20.6
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.1787 of 5 stars
3.11.00.00.01.74.20.6
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
4.2995 of 5 stars
4.21.00.04.92.91.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cadre Holdings, Inc. stock logo
CDRE
Cadre
3.00
Buy$37.0013.01% Upside
Liquidia Co. stock logo
LQDA
Liquidia
3.00
Buy$26.6777.42% Upside
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.29
Hold$10.1676.34% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.47
Hold$35.8680.82% Upside

Current Analyst Ratings Breakdown

Latest TMCI, TNDM, CDRE, and LQDA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/28/2025
Liquidia Co. stock logo
LQDA
Liquidia
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$36.00 ➝ $37.00
5/28/2025
Liquidia Co. stock logo
LQDA
Liquidia
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$20.00 ➝ $23.00
5/28/2025
Liquidia Co. stock logo
LQDA
Liquidia
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$25.00
5/28/2025
Liquidia Co. stock logo
LQDA
Liquidia
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$29.00 ➝ $35.00
5/27/2025
Liquidia Co. stock logo
LQDA
Liquidia
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/22/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$20.00 ➝ $24.00
5/21/2025
Liquidia Co. stock logo
LQDA
Liquidia
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
5/19/2025
Liquidia Co. stock logo
LQDA
Liquidia
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetMarket Perform ➝ Underperform$13.00
5/12/2025
Liquidia Co. stock logo
LQDA
Liquidia
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
5/12/2025
Liquidia Co. stock logo
LQDA
Liquidia
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$29.00 ➝ $29.00
5/9/2025
Liquidia Co. stock logo
LQDA
Liquidia
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetStrong-Buy ➝ Strong-Buy$27.00 ➝ $29.00
(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$559.81M2.38$1.43 per share22.89$5.25 per share6.24
Liquidia Co. stock logo
LQDA
Liquidia
$14.14M90.84N/AN/A$0.73 per share20.59
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$210.82M1.72N/AN/A$2.24 per share2.57
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$982.95M1.34N/AN/A$4.81 per share4.12
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$38.64M$0.9539.4524.071.586.34%12.88%6.06%8/8/2025 (Estimated)
Liquidia Co. stock logo
LQDA
Liquidia
-$78.50M-$1.58N/AN/AN/A-765.38%-163.21%-67.14%8/6/2025 (Estimated)
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$49.53M-$0.85N/AN/AN/A-30.33%-51.12%-26.36%8/5/2025 (Estimated)
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$222.61M-$2.78N/AN/AN/A-14.84%-44.19%-11.99%8/7/2025 (Estimated)

Latest TMCI, TNDM, CDRE, and LQDA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Liquidia Co. stock logo
LQDA
Liquidia
-$0.42-$0.45-$0.03-$0.45$3.23 million$3.12 million
5/8/2025Q1 2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$0.31-$0.25+$0.06-$0.25$52.07 million$52.57 million
5/6/2025Q1 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.13$0.23+$0.10$0.23$121.53 million$130.11 million
4/30/2025Q1 2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.60-$0.67-$0.07-$1.97$220.19 million$234.42 million
3/19/2025Q4 2024
Liquidia Co. stock logo
LQDA
Liquidia
-$0.38-$0.46-$0.08-$0.46$4.60 million$2.92 million
3/11/2025Q4 2024
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.48$0.32-$0.16$0.32$170.95 million$175.98 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.381.16%+63.55%40.00%2 Years
Liquidia Co. stock logo
LQDA
Liquidia
N/AN/AN/AN/AN/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A

Latest TMCI, TNDM, CDRE, and LQDA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/22/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
quarterly$0.09501.29%5/2/20255/2/20255/16/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.65
3.01
1.96
Liquidia Co. stock logo
LQDA
Liquidia
N/A
6.33
6.33
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.51
4.12
2.98
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
1.29
2.90
2.32

Institutional Ownership

CompanyInstitutional Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
43.95%
Liquidia Co. stock logo
LQDA
Liquidia
64.54%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
84.08%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
37.00%
Liquidia Co. stock logo
LQDA
Liquidia
26.50%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
27.72%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
1.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2,24040.66 million25.58 millionOptionable
Liquidia Co. stock logo
LQDA
Liquidia
5085.49 million59.16 millionOptionable
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
25062.89 million47.08 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,60066.61 million64.23 millionOptionable

Recent News About These Companies

Tandem agrees to pay $36M to settle Roche patent litigation

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cadre stock logo

Cadre NYSE:CDRE

$32.74 -0.06 (-0.18%)
Closing price 05/30/2025 03:59 PM Eastern
Extended Trading
$32.77 +0.03 (+0.09%)
As of 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cadre Holdings, Inc. manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, Los Alamos National Laboratories, Waste Isolation Plant, and various foreign government agencies. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.

Liquidia stock logo

Liquidia NASDAQ:LQDA

$15.03 +0.03 (+0.20%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$14.92 -0.11 (-0.73%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Treace Medical Concepts stock logo

Treace Medical Concepts NASDAQ:TMCI

$5.76 -0.10 (-1.71%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$5.74 -0.02 (-0.35%)
As of 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Tandem Diabetes Care stock logo

Tandem Diabetes Care NASDAQ:TNDM

$19.83 -1.45 (-6.81%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$19.82 -0.01 (-0.05%)
As of 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.